SCHEMBL6559569

SCHEMBL6559569

COC(=O)c1ccc2c(c1)C(N(C)S(=O)(=O)N(C)C)CC(C)(C)O2

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 4/20 0.37
SMN1; SMN2 Q16637 4/20 0.37
NPC1 O15118 2/20 0.37
CASP3 P42574 1/20 0.37
SENP7 Q9BQF6 1/20 0.37
HPGD P15428 2/20 0.36
ALOX5 P09917 1/20 0.36
ALDH1A1 P00352 4/20 0.35
KDM4E B2RXH2 3/20 0.35
MEN1 O00255 2/20 0.35
KMT2A Q03164 2/20 0.35
HTT P42858 2/20 0.35
THRB P10828 1/20 0.35
TSHR P16473 3/20 0.34
LMNA P02545 2/20 0.34
MAPT P10636 2/20 0.34
MAPK1 P28482 1/20 0.34
NPSR1 Q6W5P4 1/20 0.34
KCNA5 P22460 3/20 0.34
CA12 O43570 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6559277 0.90 KCNE1 (0.40) RAB9ASMN1; SMN2NPC1HPGDALOX5
SCHEMBL6559550 0.89 MEN1 (0.37) ALDH1A1MEN1KMT2AMAPK1KCNA5
SCHEMBL6560813 0.88 KCNE1 (0.42) RAB9ASMN1; SMN2NPC1HPGDALDH1A1
SCHEMBL6559826 0.87 SMN1; SMN2 (0.36) RAB9ASMN1; SMN2NPC1HPGDALOX5
SCHEMBL6558778 0.87 HTR1A (0.36) RAB9ASMN1; SMN2NPC1CASP3SENP7
SCHEMBL6559333 0.84 KCNE1 (0.44) HPGDALDH1A1KDM4EMEN1KMT2A
SCHEMBL6559205 0.82 SMN1; SMN2 (0.38) RAB9ASMN1; SMN2NPC1HPGDALOX5
SCHEMBL6558679 0.80 HPGD (0.41) RAB9ASMN1; SMN2NPC1HPGDALOX5
SCHEMBL6560975 0.79 KCNE1 (0.47)
SCHEMBL6559604 0.79 MEN1 (0.36) RAB9ASMN1; SMN2NPC1HPGDALOX5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0807629-B1 Sulfonamido substituted chromane derivatives, method for their preparation, their use as medicaments or diagnostic agents aswell as medicaments containing them AVENTIS PHARMA GMBH (DE) 2004-03-03 EP disclosed
US-6191164-B1 POTASSIUM CHANNEL MODULATORS; ANTIULCER AGENTS HOECHST AKTIENGESELLSCHAFT (DE) 2001-02-20 US disclosed
EP-0807629-A1 Sulfonamido substituted chromane derivatives, method for their preparation, their use as medicaments or diagnostic agents aswell as medicaments containing them HOECHST AKTIENGESELLSCHAFT (DE) 1997-11-19 EP disclosed